251 related articles for article (PubMed ID: 25658856)
1. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.
Cattane N; Minelli A; Milanesi E; Maj C; Bignotti S; Bortolomasi M; Bocchio Chiavetto L; Gennarelli M
PLoS One; 2015; 10(2):e0116686. PubMed ID: 25658856
[TBL] [Abstract][Full Text] [Related]
2. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
[TBL] [Abstract][Full Text] [Related]
3. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders.
Miyamoto K; Funahashi Y; Yoshino Y; Kawabe K; Yamazaki K; Ozaki Y; Mori Y; Ochi S; Iga JI; Ueno SI
Asian J Psychiatr; 2020 Aug; 52():102112. PubMed ID: 32371365
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
Li Z; Li D; Chen X
J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
[TBL] [Abstract][Full Text] [Related]
9. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
10. A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.
Chen X; Long F; Cai B; Chen X; Chen G
J Comp Neurol; 2018 Jan; 526(1):59-79. PubMed ID: 28856687
[TBL] [Abstract][Full Text] [Related]
11. Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients.
Yu HC; Wu J; Zhang HX; Zhang GL; Sui J; Tong WW; Zhang XY; Nie LL; Duan JH; Zhang LR; Lv LX
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():23-9. PubMed ID: 25985888
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Gene Expression and Methylation Profiles of TCF4, MBP, and EGR1 in Peripheral Blood of Drug-Free Patients with Schizophrenia: Correlations with Psychopathology, Intelligence, and Cognitive Impairment.
Yazarlou F; Tabibian M; Azarnezhad A; Sadeghi Rad H; Lipovich L; Sanati G; Mostafavi Abdolmaleky H; Alizadeh F
J Mol Neurosci; 2023 Oct; 73(9-10):738-750. PubMed ID: 37668894
[TBL] [Abstract][Full Text] [Related]
13. Post-mortem molecular profiling of three psychiatric disorders.
Ramaker RC; Bowling KM; Lasseigne BN; Hagenauer MH; Hardigan AA; Davis NS; Gertz J; Cartagena PM; Walsh DM; Vawter MP; Jones EG; Schatzberg AF; Barchas JD; Watson SJ; Bunney BG; Akil H; Bunney WE; Li JZ; Cooper SJ; Myers RM
Genome Med; 2017 Jul; 9(1):72. PubMed ID: 28754123
[TBL] [Abstract][Full Text] [Related]
14. Identification of a biological signature for schizophrenia in serum.
Schwarz E; Guest PC; Rahmoune H; Harris LW; Wang L; Leweke FM; Rothermundt M; Bogerts B; Koethe D; Kranaster L; Ohrmann P; Suslow T; McAllister G; Spain M; Barnes A; van Beveren NJ; Baron-Cohen S; Steiner J; Torrey FE; Yolken RH; Bahn S
Mol Psychiatry; 2012 May; 17(5):494-502. PubMed ID: 21483431
[TBL] [Abstract][Full Text] [Related]
15. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
[TBL] [Abstract][Full Text] [Related]
16. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.
Xiao X; Zhang C; Grigoroiu-Serbanescu M; Wang L; Li L; Zhou D; Yuan TF; Wang C; Chang H; Wu Y; Li Y; Wu DD; Yao YG; Li M
Mol Psychiatry; 2018 Sep; 23(9):1957-1967. PubMed ID: 29158582
[TBL] [Abstract][Full Text] [Related]
17. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.
Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S
J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557
[TBL] [Abstract][Full Text] [Related]
19. A novel relationship for schizophrenia, bipolar and major depressive disorder Part 7: A hint from chromosome 7 high density association screen.
Chen X; Long F; Cai B; Chen X; Chen G
Behav Brain Res; 2015 Oct; 293():241-51. PubMed ID: 26192912
[TBL] [Abstract][Full Text] [Related]
20. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
